Hi jooboy. Do you think their re-rating against Thoratec with the analysts has anything to do with the SP increase on the nasdaq?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025